Article info
PDFOriginal research
More than consent for ethical open-label placebo research
- Correspondence to Dr Laura Specker Sullivan, Philosophy Department, Fordham University, Bronx, NY 10458, USA; lspeckersullivan{at}fordham.edu
Citation
More than consent for ethical open-label placebo research
Publication history
- Received October 18, 2019
- Revised June 24, 2020
- Accepted June 26, 2020
- First published September 3, 2020.
Online issue publication
January 07, 2022
Article Versions
- Previous version (7 January 2022).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.
Other content recommended for you
- Epistemic injustice, children and mental illness
- Physician perspectives on placebo ethics
- Epistemic injustice in healthcare encounters: evidence from chronic fatigue syndrome
- Lay perspectives of the open-label placebo rationale: a qualitative study of participants in an experimental trial
- Open notes in patient care: confining deceptive placebos to the past?
- Replication crisis and placebo studies: rebooting the bioethical debate
- Impact of a 12-week open-label placebo treatment on headache days in episodic and chronic migraine: a study protocol for a parallel-group, multicentre, randomised controlled trial
- Effects of placebos without deception compared with no treatment: protocol for a systematic review and meta-analysis
- Placebos in chronic pain: evidence, theory, ethics, and use in clinical practice
- The ethics of the placebo in clinical practice revisited